These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6478648)

  • 1. Local administration of cytostatic drug 4-hydroperoxy-cyclophosphamide (4-HPCY) facilitates cell-mediated immune reactions.
    Boerrigter GH; Scheper RJ
    Clin Exp Immunol; 1984 Oct; 58(1):161-6. PubMed ID: 6478648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intradermal administration of 4-hydroperoxy-cyclophosphamide during contact sensitization potentiates effector T cell responsiveness in draining lymph nodes.
    Boerrigter GH; de Groot J; Scheper RJ
    Immunopharmacology; 1986 Feb; 11(1):13-20. PubMed ID: 3485619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune suppression with supraoptimal doses of antigen in contact sensitivity. I. Demonstration of suppressor cells and their sensitivity to cyclophosphamide.
    Sy MS; Miller SD; Claman HN
    J Immunol; 1977 Jul; 119(1):240-4. PubMed ID: 68972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of the relation between suppressor and effector mechanisms in contact sensitivity in the guinea-pig.
    Parker D; Turk JL
    Immunology; 1982 Sep; 47(1):61-6. PubMed ID: 6214499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in dendritic cell phenotype and function associated with immunoenhancing effects of a subcutaneously administered cyclophosphamide derivative.
    Limpens J; Van Meijer M; Van Santen HM; Germeraad WT; Hoeben-Schornagel K; Breel M; Scheper RJ; Kraal G
    Immunology; 1991 Jul; 73(3):255-63. PubMed ID: 1879874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor regression and induction of anti-tumor immunity by local chemotherapy of guinea-pigs bearing a line-10 hepatocarcinoma.
    Claessen AM; Valster H; Bril H; Steerenberg PA; Tan BT; Scheper RJ
    Int J Cancer; 1991 Feb; 47(4):626-32. PubMed ID: 1995491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of various cytostatic drugs as local immunotherapeutic agents.
    Scheper RJ; Vos A; de Groot J; Boerrigter GH
    Invest New Drugs; 1984; 2(2):221-5. PubMed ID: 6332093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of T suppressor cell function by local administration of an active cyclophosphamide derivative at the sensitization site.
    Limpens J; Scheper RJ
    Clin Exp Immunol; 1991 Jun; 84(3):383-8. PubMed ID: 1828396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct in vitro evidence for different susceptibilities to 4-hydroperoxycyclophosphamide of antigen-primed T cells regulating humoral and cell-mediated immune responses to sheep erythrocytes: a possible explanation for the inverse action of cyclophosphamide on humoral and cell-mediated immune responses.
    Diamantstein T; Klos M; Hahn H; Kaufmann SH
    J Immunol; 1981 May; 126(5):1717-9. PubMed ID: 6452475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epicutaneous induction of hyporeactivity in contact sensitization. Demonstration of suppressor cells induced by contact with 2,4-dinitrothiocyanatebenzene.
    Sommer G; Parker D; Turk JL
    Immunology; 1975 Sep; 29(3):517-25. PubMed ID: 1080744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differing mechanisms of tolerance and desensitization to dinitrochlorobenzene in guinea pigs.
    Polak L; Geleick H
    Eur J Immunol; 1975 Feb; 5(2):94-9. PubMed ID: 1086223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapeutic effects of local chemotherapy with an active metabolite of cyclophosphamide.
    Scheper RJ; Limpens J; Tan BT; Valster H; Claessen AM; Claessen ME
    Methods Find Exp Clin Pharmacol; 1987 Sep; 9(9):611-5. PubMed ID: 3325717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal by cyclophosphamide of tolerance in contact sensitization. Tolerance induced by prior feeding with DNCB.
    Polak L; Geleick H; Turk JL
    Immunology; 1975 May; 28(5):939-42. PubMed ID: 1132885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of cyclophosphamide on immunological control mechanisms.
    Turk JL; Parker D; Cameron AE
    Int J Tissue React; 1984; 6(3):205-11. PubMed ID: 6480267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of sheep erythrocyte (SRBC)-induced pleurisy in non-sensitized mice by cyclophosphamide: demonstration of natural cell-mediated immune reactivity to SRBC.
    Yamamoto S; Higuchi Y; Teshima H
    Immunology; 1982 Sep; 47(1):31-40. PubMed ID: 7118162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of the delayed-type hypersensitivity reaction by oxazaphosphorines.
    Turk JL
    Methods Find Exp Clin Pharmacol; 1987 Sep; 9(9):605-10. PubMed ID: 3325716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elimination of immune suppressor mechanisms in humans by oxazaphosphorines.
    Berd D; Mastrangelo MJ
    Methods Find Exp Clin Pharmacol; 1987 Sep; 9(9):569-77. PubMed ID: 2963936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressor cells in different types of unresponsiveness to DNCB contact sensitivity in guinea-pigs.
    Polak L
    Clin Exp Immunol; 1975 Mar; 19(3):543-9. PubMed ID: 1204250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclophosphamide-induced tumour regression of cyclophosphamide-resistant L5178Y lymphoma through suppressor cells elimination.
    Andrade-Mena CE
    Int J Tissue React; 1994; 16(2):95-103. PubMed ID: 7960506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-mediated immunity is enhanced by cytostatic drugs continuously released at the site of antigenic stimulation.
    Claessen AM; Valster H; Bril H; Meyer S; Scheper RJ
    Cancer Immunol Immunother; 1989; 28(2):131-5. PubMed ID: 2917364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.